Active Ingredient: ETHINYL ESTRADIOL; NORETHINDRONE
Proprietary Name: BALZIVA-21
Dosage Form; Route of Administration: TABLET; ORAL-21
Strength: 0.035MG;0.4MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A076198
Product Number: 001
Approval Date: Apr 22, 2004
Applicant Holder Full Name: BARR LABORATORIES INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
